Anti-adalimumab and anti-infliximab antibodies developed in psoriasis vulgaris patients reduced the efficacy of biologics: Report of two cases
Article first published online: 18 FEB 2013
© 2013 Japanese Dermatological Association
The Journal of Dermatology
Special Issue: Special Issue: Genetics of hypopigmentary disorders (pages 309-356)
Volume 40, Issue 5, pages 389–392, May 2013
How to Cite
Matsumoto, Y., Maeda, T., Tsuboi, R. and Okubo, Y. (2013), Anti-adalimumab and anti-infliximab antibodies developed in psoriasis vulgaris patients reduced the efficacy of biologics: Report of two cases. The Journal of Dermatology, 40: 389–392. doi: 10.1111/1346-8138.12093
- Issue published online: 14 MAY 2013
- Article first published online: 18 FEB 2013
- Manuscript Accepted: 12 DEC 2012
- Manuscript Received: 3 JUN 2012
Options for accessing this content:
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.